Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Cecilia Jones

CFO at Agios Pharmaceuticals, Inc. (AGIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $334K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 6SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 3,14154,998 held (−5%) $34.71 $109K -8.4%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 59438,800 held (−2%) $28.96 $17K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 1,68142,785 held (−4%) $28.96 $49K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 1,18745,598 held (−3%) $28.96 $34K +9.8%
Mar 3SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 1,57349,328 held (−3%) $28.96 $46K +9.8%
Jan 2SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 2,93237,394 held (−7%) $27.09 $79K +17.4%
  • Sell

    CFO Cecilia Jones sold $109K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Cecilia Jones sold $17K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Cecilia Jones sold $49K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Cecilia Jones sold $34K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Cecilia Jones sold $46K of AGIO at $28.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Cecilia Jones sold $79K of AGIO at $27.09 — pre-scheduled 10b5-1 plan sale.